Williams D, Longmore G, Matta K L, Schachter H
J Biol Chem. 1980 Dec 10;255(23):11253-61.
The preceding paper (Williams, D., and Schachter, H. (1980) J. Biol. Chem. 255, 0000-0000) described a novel N-acetylglucosaminyltransferase in canine submaxillary gland microsomes which catalyzed the incorporation of GlcNAc into mucin acceptors. We show in the present report that the enzyme catalyzes th following reaction: UDP-GlcNAc + Gal beta 1-3GalNAc-X leads to Gal beta 1-3(GlcNAc beta 1-6) GalNAc-X + UDP, where X can be porcine submaxillary mucin polypeptide (Km = 5.2 mM), antifreeze glycoprotein polypeptide (Km = 23 mM), alpha-O-p-nitrophenyl (Km = 0.52 mM), beta-O-p-nitrophenyl (Km = 0.92 mM), alpha-O-o-nitrophenyl (Km = 0.86 mM), alpha-O-benzyl (Km = 0.77 mM), alpha-O-methyl (Km = 4.2 mM), or -H (Km = 1.2 mM). Ineffective acceptors (< 5% of the activity with Gal beta 1-3GalNAc-alpha-p-nitrophenyl) are asialo-ovine submaxillary mucin, asialo-alpha 1 acid glycoprotein, Gal beta 1-3GlcNAc-beta-p-nitrophenyl, Gal beta 1-3GlcNAc-alpha-methyl, Gal beta1-3GlcNAc, Gal beta 1-3-N-acetylgalactosaminitol, and D-fucose beta 1-3GalNAc-alpha-benzyl, indicating that both the Gal and GalNAc residues are essential for acceptor activity. The beta 1 leads to 6-linkage of GlcNAc to GalNAc in the acceptor Gal beta 1-3GalNAc-alpha-O-benzyl was established by methylation analysis and high resolution 1H nuclear magnetic resonance spectroscopy of a large scale preparation of product. Preliminary evidence has been obtained indicating that sialic acid linked alpha 2-6 to GalNAc or L-fucose linked alpha 1-2 to Gal inhibit the action of the beta 6-N-acetylglucosaminyltransferase on Gal beta 1-3GalNAc-porcine submaxillary mucin polypeptide.
前文(威廉姆斯,D.,和沙克特,H.(1980年)《生物化学杂志》255卷,0000 - 0000页)描述了犬颌下腺微粒体中一种新型的N - 乙酰葡糖胺基转移酶,该酶催化将GlcNAc掺入粘蛋白受体中。我们在本报告中表明,该酶催化以下反应:UDP - GlcNAc + Galβ1 - 3GalNAc - X → Galβ1 - 3(GlcNAcβ1 - 6)GalNAc - X + UDP,其中X可以是猪颌下粘蛋白多肽(Km = 5.2 mM)、抗冻糖蛋白多肽(Km = 23 mM)、α - O - 对硝基苯基(Km = 0.52 mM)、β - O - 对硝基苯基(Km = 0.92 mM)、α - O - 邻硝基苯基(Km = 0.86 mM)、α - O - 苄基(Km = 0.77 mM)或 - H(Km = 1.2 mM)。无效受体(相对于Galβ1 - 3GalNAc - α - 对硝基苯基的活性小于5%)包括脱唾液酸羊颌下粘蛋白、脱唾液酸α1酸性糖蛋白、Galβ1 - 3GlcNAc - β - 对硝基苯基、Galβ1 - 3GlcNAc - α - 甲基、Galβ1 - 3GlcNAc、Galβ1 - 3 - N - 乙酰半乳糖醇和D - 岩藻糖β1 - 3GalNAc - α - 苄基,这表明Gal和GalNAc残基对于受体活性都是必不可少的。通过对大规模制备产物的甲基化分析和高分辨率1H核磁共振光谱,确定了受体Galβ1 - 3GalNAc - α - O - 苄基中GlcNAc与GalNAc的β1→6连接。已获得初步证据表明,与GalNAc以α2 - 6连接的唾液酸或与Gal以α1 - 2连接的L - 岩藻糖会抑制β6 - N - 乙酰葡糖胺基转移酶对Galβ1 - 3GalNAc - 猪颌下粘蛋白多肽的作用。